Spandidos Publications style
Zhu X, Sun Y, Cai R, Zhang W, Zhang X, Song A, Chen X, Liu C and Zhou J: Individualized management strategies for advanced non‑small cell lung cancer with <em>EGFR</em> exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report. Oncol Lett 31: 88, 2026.
APA
Zhu, X., Sun, Y., Cai, R., Zhang, W., Zhang, X., Song, A. ... Zhou, J. (2026). Individualized management strategies for advanced non‑small cell lung cancer with <em>EGFR</em> exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report. Oncology Letters, 31, 88. https://doi.org/10.3892/ol.2025.15441
MLA
Zhu, X., Sun, Y., Cai, R., Zhang, W., Zhang, X., Song, A., Chen, X., Liu, C., Zhou, J."Individualized management strategies for advanced non‑small cell lung cancer with <em>EGFR</em> exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report". Oncology Letters 31.2 (2026): 88.
Chicago
Zhu, X., Sun, Y., Cai, R., Zhang, W., Zhang, X., Song, A., Chen, X., Liu, C., Zhou, J."Individualized management strategies for advanced non‑small cell lung cancer with <em>EGFR</em> exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report". Oncology Letters 31, no. 2 (2026): 88. https://doi.org/10.3892/ol.2025.15441
